Mollie Leoni - 27 Jan 2026 Form 4 Insider Report for Kura Oncology, Inc. (KURA)

Role
Chief Medical Officer
Signature
Teresa Bair, Attorney-in-fact for Mollie Leoni
Issuer symbol
KURA
Transactions as of
27 Jan 2026
Net transactions value
-$69,209
Form type
4
Filing time
27 Jan 2026, 21:35:05 UTC
Previous filing
06 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Leoni Mollie Chief Medical Officer C/O KURA ONCOLOGY, INC., 4930 DIRECTORS PLACE, SUITE 500, SAN DIEGO Teresa Bair, Attorney-in-fact for Mollie Leoni 27 Jan 2026 0002051106

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KURA Common Stock Sale $30,924 -3,655 -1.3% $8.46 271,799 27 Jan 2026 Direct F1
transaction KURA Common Stock Sale $18,893 -2,233 -0.82% $8.46 269,566 27 Jan 2026 Direct F2
transaction KURA Common Stock Sale $8,046 -951 -0.35% $8.46 268,615 27 Jan 2026 Direct F3
transaction KURA Common Stock Sale $11,346 -1,341 -0.5% $8.46 267,274 27 Jan 2026 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sell-to-cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/2/25.
F2 Sell-to-cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/26/24.
F3 Sell-to-cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 2/16/23.
F4 Sell-to-cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/26/22.